Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, according to a research letter published online Oct. 14 ...

With Gilead sprinting to a likely approval next year for its long-acting pre-exposure | With GSK girding for competition from ...

The new rule was contained within a larger proposal to ensure contraceptive coverage in the face of Republican attacks.

In the last 30 years, HIV rates have gone down, in large part because of the game-changing prescription drug pre-exposure ...

The Biden-Harris administration has a historic opportunity to help end HIV. New, cutting-edge drugs that prevent HIV are ...

As groundbreaking studies continue to reshape the human immunodeficiency virus (HIV) landscape, emerging therapies and ...

Those include Sunlenca, which is approved for resistant HIV as a twice-yearly injection after an initial oral regimen, and ...

Learn about the changing trend in pre exposure prophylaxis medication prescription for HIV patients in the US over the past ...

Lenacapavir is a long-acting pre-exposure prophylaxis (PrEP) product ... women – those who identify with the gender they were born with – contracted HIV while on the drug. Hasina Subedar, senior ...

(HealthDay News) — Preexposure prophylaxis (PrEP) use increased between 2013 and ... Generic TDF/FTC reached the highest monthly share of users among all medications from December 2021 to December ...